302 related articles for article (PubMed ID: 27342578)
1. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
2. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
[TBL] [Abstract][Full Text] [Related]
3. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.
Rogounovitch TI; Bychkov A; Takahashi M; Mitsutake N; Nakashima M; Nikitski AV; Hayashi T; Hirokawa M; Ishigaki K; Shigematsu K; Bogdanova T; Matsuse M; Nishihara E; Minami S; Yamanouchi K; Ito M; Kawaguchi T; Kondo H; Takamura N; Ito Y; Miyauchi A; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2015 Mar; 25(3):333-40. PubMed ID: 25562676
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
6. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
7. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
[TBL] [Abstract][Full Text] [Related]
8. Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.
Liyanarachchi S; Wojcicka A; Li W; Czetwertynska M; Stachlewska E; Nagy R; Hoag K; Wen B; Ploski R; Ringel MD; Kozłowicz-Gudzinska I; Gierlikowski W; Jazdzewski K; He H; de la Chapelle A
Thyroid; 2013 Dec; 23(12):1532-40. PubMed ID: 23659773
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
10. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
11. FOXE1 association with differentiated thyroid cancer and its progression.
Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
[TBL] [Abstract][Full Text] [Related]
12. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
Kula D; Kalemba M; Puch Z; Polańska J; Świerniak M; Rusinek D; Żebracka-Gala J; Kowalska M; Handkiewicz-Junak D; Kowal M; Tyszkiewicz T; Piasna E; Czarniecka A; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Jarząb B
Endokrynol Pol; 2017; 68(3):283-289. PubMed ID: 28660995
[TBL] [Abstract][Full Text] [Related]
13. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.
Jendrzejewski J; He H; Radomska HS; Li W; Tomsic J; Liyanarachchi S; Davuluri RV; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2012 May; 109(22):8646-51. PubMed ID: 22586128
[TBL] [Abstract][Full Text] [Related]
14. The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations.
Mussazhanova Z; Rogounovitch TI; Saenko VA; Krykpayeva A; Espenbetova M; Azizov B; Kondo H; Matsuda K; Kalmatayeva Z; Issayeva R; Yeleubayeva Z; Madiyeva M; Mukanova A; Sandybayev M; Bolsynbekova S; Kozykenova Z; Yamashita S; Nakashima M
Front Endocrinol (Lausanne); 2020; 11():543500. PubMed ID: 33551988
[TBL] [Abstract][Full Text] [Related]
15. Association between GWAS-Derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer.
Świerniak M; Wójcicka A; Czetwertyńska M; Długosińska J; Stachlewska E; Gierlikowski W; Kot A; Górnicka B; Koperski Ł; Bogdańska M; Wiechno W; Jażdżewski K
Clin Cancer Res; 2016 Mar; 22(5):1111-9. PubMed ID: 26490305
[TBL] [Abstract][Full Text] [Related]
16. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.
Jendrzejewski J; Thomas A; Liyanarachchi S; Eiterman A; Tomsic J; He H; Radomska HS; Li W; Nagy R; Sworczak K; de la Chapelle A
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1370-7. PubMed ID: 26274343
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of GWAS variants associated with differentiated thyroid cancer.
Jendrzejewski JP; Sworczak K; Comiskey DF; de la Chapelle A
Endokrynol Pol; 2019; 70(5):423-429. PubMed ID: 31681970
[TBL] [Abstract][Full Text] [Related]
18. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.
Wang F; Yan D; Ji X; Han J; Chen M; Qiao H; Zhang S
Oncotarget; 2016 Jul; 7(27):41336-41345. PubMed ID: 27191655
[TBL] [Abstract][Full Text] [Related]
19. Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.
Bychkov A; Saenko V; Nakashima M; Mitsutake N; Rogounovitch T; Nikitski A; Orim F; Yamashita S
Thyroid; 2013 Jul; 23(7):817-28. PubMed ID: 23327367
[TBL] [Abstract][Full Text] [Related]
20. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
